Jefferies Raises PT On ZOLL Medical To $58

Symbols: ZOLL
Share

Jefferies & Company has raised the price target on ZOLL Medical Corporation (NASDAQ: ZOLL) from $53 to $58 and maintains its Buy rating.


 
 
< Previous
Jefferies Raises PT To $34 On QLIK
Next >
Wunderlich Securities Downgrades NetScout Systems' Rating and PT (NTCT, RVBD)
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Brain Trust